There have been 50 recent insider transactions recorded for Olema Pharmaceuticals, Inc. (OLMA), including 23 buys and 18 sells. Total insider buying was valued at $24.66M and total insider selling at $15.35M.
Notable insiders with recent activity include Mitchell Shawnte, Myles David C., Bohen Sean. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — OLMA
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2026-03-04 |
Mitchell Shawnte |
Chief Legal Officer |
Informative Sell |
233 |
$24.69 |
$5.75K |
- |
| 2026-03-03 |
Mitchell Shawnte |
Chief Legal Officer |
Informative Sell |
15,000 |
$23.01 |
$345.15K |
- |
| 2026-02-02 |
Mitchell Shawnte |
Chief Legal Officer |
RSU Award |
56,250 |
$25.65 |
$1.44M |
56,250 |
| 2026-02-02 |
Myles David C. |
Ch. Discov. & Non-clin Dev Off |
RSU Award |
106,250 |
$25.65 |
$2.73M |
106,250 |
| 2026-02-02 |
Bohen Sean |
President and CEO |
RSU Award |
275,000 |
$25.65 |
$7.05M |
275,000 |
| 2026-02-02 |
Zojwalla Naseem |
Chief Medical Officer |
RSU Award |
106,250 |
$25.65 |
$2.73M |
106,250 |
| 2026-02-02 |
Austin Sasha Lu |
VP of Finance and Controller |
RSU Award |
11,700 |
- |
- |
16,188 |
| 2026-02-01 |
Austin Sasha Lu |
VP of Finance and Controller |
Unknown |
13,000 |
$2.44 |
$31.72K |
- |
| 2026-01-30 |
Austin Sasha Lu |
VP of Finance and Controller |
Unknown |
45,000 |
$4.37 |
$196.65K |
- |
| 2026-01-20 |
Harmon Cyrus |
Director |
Informative Sell |
10,000 |
$26.88 |
$268.8K |
727,770 |
| 2026-01-15 |
Kovacs Shane William Charles |
Ch. Operating & Financial Off. |
Informative Sell |
100,000 |
$28.73 |
$2.87M |
139,727 |
| 2026-01-14 |
Myles David C. |
Ch. Discov. & Non-clin Dev Off |
Option Exercise (Sell) |
50,000 |
$4.87 |
$243.5K |
50,000 |
| 2026-01-14 |
Harmon Cyrus |
Director |
Informative Sell |
3,489 |
$29.12 |
$101.6K |
737,770 |
| 2026-01-13 |
Myles David C. |
Ch. Discov. & Non-clin Dev Off |
Option Exercise (Sell) |
50,000 |
$4.87 |
$243.5K |
100,000 |
| 2026-01-13 |
Kovacs Shane William Charles |
Ch. Operating & Financial Off. |
Informative Sell |
3,822 |
$28.01 |
$107.05K |
239,727 |
| 2026-01-12 |
Myles David C. |
Ch. Discov. & Non-clin Dev Off |
Informative Sell |
10,000 |
$28.34 |
$283.4K |
144,846 |
| 2025-12-26 |
Bohen Sean |
President and CEO |
Gift (Given) |
8,500 |
- |
- |
237,650 |
| 2025-12-23 |
Zojwalla Naseem |
Chief Medical Officer |
Informative Sell |
99,509 |
$27.66 |
$2.75M |
4,488 |
| 2025-12-22 |
Zojwalla Naseem |
Chief Medical Officer |
Informative Sell |
100,000 |
$28.04 |
$2.8M |
53,997 |
| 2025-12-22 |
Harmon Cyrus |
Director |
Informative Sell |
2,881 |
$28.53 |
$82.19K |
741,259 |
| 2025-12-19 |
Clark Ian T |
Director |
Option Exercise (Sell) |
21,520 |
$3.61 |
$77.69K |
- |
| 2025-12-19 |
Myles David C. |
Ch. Discov. & Non-clin Dev Off |
Gift (Given) |
9,000 |
- |
- |
542,881 |
| 2025-12-19 |
Zojwalla Naseem |
Chief Medical Officer |
Informative Sell |
12,921 |
$28.93 |
$373.8K |
103,997 |
| 2025-12-08 |
Kovacs Shane William Charles |
Ch. Operating & Financial Off. |
Gift (Given) |
75,000 |
- |
- |
243,549 |
| 2025-11-26 |
Kovacs Shane William Charles |
Ch. Operating & Financial Off. |
Gift (Given) |
225,000 |
- |
- |
318,549 |
| 2025-11-25 |
Rappaport Andrew |
Director |
Gift (Given) |
35,868 |
- |
- |
- |
| 2025-11-21 |
Rappaport Andrew |
Director |
Option Exercise (Sell) |
35,868 |
$0.39 |
$13.99K |
- |
| 2025-09-18 |
Harmon Cyrus |
Director |
Informative Sell |
3,086 |
$8.32 |
$25.68K |
117,028 |
| 2025-09-16 |
Harmon Cyrus |
Director |
Informative Sell |
1,914 |
$8.08 |
$15.47K |
120,114 |
| 2025-06-11 |
Bvf Partners L P/il |
Other: See Explanation of Responses |
RSU Award |
24,150 |
$4.08 |
$98.53K |
24,150 |
| 2025-06-11 |
Rappaport Andrew |
Director |
RSU Award |
24,150 |
$4.08 |
$98.53K |
24,150 |
| 2025-06-11 |
Butitta Cynthia M |
Director |
RSU Award |
24,150 |
$4.08 |
$98.53K |
24,150 |
| 2025-06-11 |
Clark Ian T |
Director |
RSU Award |
24,150 |
$4.08 |
$98.53K |
24,150 |
| 2025-06-11 |
Garland J. Scott |
Director |
RSU Award |
24,150 |
$4.08 |
$98.53K |
24,150 |
| 2025-06-11 |
Horning Sandra |
Director |
RSU Award |
24,150 |
$4.08 |
$98.53K |
24,150 |
| 2025-06-11 |
Graham G. Walmsley |
Director |
RSU Award |
24,150 |
$4.08 |
$98.53K |
24,150 |
| 2025-06-11 |
Larson Yi |
Director |
RSU Award |
24,150 |
$4.08 |
$98.53K |
24,150 |
| 2025-06-11 |
Hrustanovic Gorjan |
Director |
RSU Award |
24,150 |
$4.08 |
$98.53K |
24,150 |
| 2025-06-11 |
Harmon Cyrus |
Director |
RSU Award |
24,150 |
$4.08 |
$98.53K |
24,150 |
| 2025-02-28 |
Kovacs Shane William Charles |
Ch. Operating & Financial Off. |
RSU Award |
320,000 |
$4.37 |
$1.4M |
320,000 |
| 2025-02-28 |
Mitchell Shawnte |
Chief Legal Officer |
RSU Award |
450,000 |
$4.37 |
$1.97M |
450,000 |
| 2025-02-28 |
Myles David C. |
Ch. Discov. & Non-clin Dev Off |
RSU Award |
205,000 |
$4.37 |
$895.85K |
205,000 |
| 2025-02-28 |
Bohen Sean |
President and CEO |
RSU Award |
650,000 |
$4.37 |
$2.84M |
650,000 |
| 2025-02-28 |
Zojwalla Naseem |
Chief Medical Officer |
RSU Award |
205,000 |
$4.37 |
$895.85K |
205,000 |
| 2025-02-18 |
Mitchell Shawnte |
Officer |
Unknown |
- |
- |
- |
- |
| 2025-01-10 |
Bain Capital Life Sciences Investors, Llc |
10 Percent Owner |
Other (Buy) |
3,500,000 |
$0.00 |
$350.00 |
3,500,000 |
| 2025-01-10 |
Bvf Partners L P/il |
Other: See Explanation of Responses |
RSU Award |
22,740 |
$0.00 |
$2.27 |
336,288 |
| 2025-01-08 |
Bain Capital Life Sciences Investors, Llc |
10 Percent Owner |
Unknown |
- |
- |
- |
7,500,000 |
| 2025-01-08 |
Bain Capital Life Sciences Investors, Llc |
10 Percent Owner |
Informative Buy |
300,000 |
$5.76 |
$1.73M |
7,800,000 |
| 2024-12-17 |
Graham G. Walmsley |
Director |
Informative Sell |
700,761 |
$6.75 |
$4.73M |
- |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
